Pharmacogenomics is the investigation of how genes influence a man’s reaction to drugs. This is generally a new field consolidates pharmacology(investigation of medications) and genomics(the investigation of genes and their capacities) to create successful, safe pharmaceuticals and dosages that will be custom fitted to a man’s hereditary makeup. Computational advances in Pharmacogenomics has turned out to be a gift in research. 

These genetic differences are utilized to prevent from adverse drug reactions and to predict whether a medication will be effective for a specific individual. In the future, Pharmacogenomics will be used for the development of tailored drugs to treat wide range of health issues such as, cardiovascular diseaseAlzheimer disease , cancer, HIV/AIDS, and asthma.

Significant Universities managing Pharmacogenomics are: Harvard University, US, University of Cambridge, UK, National University of Singapore, Singapore, University of Oxford, UK, Karolin ska Institute, Sweden, Monash University, Australia, Imperial College London, UK, University of Tokyo, Japan, University of Melbourne, Australia, University of Michigan, US. 

  • Pharmacogenomics for cardiovascular diseases and drugs
  • Role of Pharmacogenomics in substance abuse and Psychological disorders

Are you interested in

Copyright © 2017-2018 Allied Academies, All Rights Reserved.